Trials / Completed
CompletedNCT05607160
A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes
ELDERLY-T: A Non-interventional, Multicentre, Prospective Observational Study on the Effectiveness and Safety of Insulin Glargine 300 U/ml in Elderly Patients ≥75 Years of Age With Type 2 Diabetes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 82 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective: \- Glycemic control after initiation or switch to insulin glargine 300 U/ml in everyday clinical practice Secondary objective: \- Treatment satisfaction
Detailed description
Study duration per participant is expected to be approximately 24 weeks
Conditions
Timeline
- Start date
- 2022-10-05
- Primary completion
- 2023-12-11
- Completion
- 2023-12-11
- First posted
- 2022-11-07
- Last updated
- 2024-04-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05607160. Inclusion in this directory is not an endorsement.